Transmedics Group Stock Today
| TMDX Stock | USD 87.24 0.62 0.71% |
Performance1 of 100
| Odds Of DistressLess than 36
|
TransMedics is trading at 87.24 as of the 19th of April 2024; that is -0.71 percent decrease since the beginning of the trading day. The stock's open price was 87.86. TransMedics has about a 36 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for TransMedics Group are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 2nd of May 2019 | Category Healthcare | Classification Health Care |
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company was founded in 1998 and is headquartered in Andover, Massachusetts. The company has 32.85 M outstanding shares of which 5.99 M shares are at this time shorted by private and institutional investors with about 8.1 trading days to cover. More on TransMedics Group
Moving against TransMedics Stock
| 0.65 | CVS | CVS Health Corp Financial Report 1st of May 2024 | PairCorr |
| 0.58 | COO | Cooper Companies Financial Report 6th of June 2024 | PairCorr |
| 0.54 | CAH | Cardinal Health Financial Report 2nd of May 2024 | PairCorr |
| 0.47 | VMD | Viemed Healthcare | PairCorr |
| 0.45 | ELMD | Electromed | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 6th of May 2024
TransMedics Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. TransMedics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding TransMedics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering TransMedics report their recommendations after researching TransMedics' financial statements, talking to executives and customers, or listening in on TransMedics' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering TransMedics Group. The TransMedics consensus assessment is calculated by taking the average forecast from all of the analysts covering TransMedics. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to TransMedics' liquidity, profitability, solvency, and operating efficiency, TransMedics Group is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of TransMedics Group is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TransMedics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to TransMedics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand TransMedics' financial leverage. It provides some insight into what part of TransMedics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TransMedics Group (TMDX) is traded on NASDAQ Exchange in USA. It is located in 200 Minuteman Road, Andover, MA, United States, 01810 and employs 584 people. TransMedics is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.89 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate TransMedics's market, we take the total number of its shares issued and multiply it by TransMedics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. TransMedics Group conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 32.85 M outstanding shares of which 5.99 M shares are at this time shorted by private and institutional investors with about 8.1 trading days to cover.
TransMedics Group currently holds about 204.46 M in cash with (13.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.41.
Check TransMedics Probability Of Bankruptcy
Ownership AllocationTransMedics maintains a total of 32.85 Million outstanding shares. The majority of TransMedics Group outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in TransMedics to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in TransMedics Group. Please pay attention to any change in the institutional holdings of TransMedics Group as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check TransMedics Ownership Details
TransMedics Stock Price Odds Analysis
Based on a normal probability distribution, the odds of TransMedics jumping above the current price in 90 days from now is about 28.48%. The TransMedics Group probability density function shows the probability of TransMedics stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.0066. This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, TransMedics will likely underperform. Additionally, transMedics Group has an alpha of 0.0815, implying that it can generate a 0.0815 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of TransMedics to move above the current price in 90 days from now is about 28.48 (This TransMedics Group probability density function shows the probability of TransMedics Stock to fall within a particular range of prices over 90 days) .
TransMedics Stock Institutional Holders
Institutional Holdings refers to the ownership stake in TransMedics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of TransMedics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing TransMedics' value.| Instituion | Recorded On | Shares | |
| Goldman Sachs Group Inc | 2023-12-31 | 794.6 K | |
| State Street Corporation | 2023-12-31 | 787.1 K | |
| Sandhill Capital Partners Llc | 2023-12-31 | 763.2 K | |
| First Light Asset Management, Llc | 2023-12-31 | 754.3 K | |
| Allspring Global Investments Holdings, Llc | 2023-12-31 | 708.3 K | |
| Geode Capital Management, Llc | 2023-12-31 | 700.7 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 687 K | |
| Bellevue Group Ag | 2023-12-31 | 518.9 K | |
| Emerald Advisers, Llc | 2023-12-31 | 516.4 K | |
| Fmr Inc | 2023-12-31 | 4.8 M | |
| Blackrock Inc | 2023-12-31 | 2.6 M |
TransMedics Historical Income Statement
TransMedics Group Income Statement is one of the three primary financial statements used for reporting TransMedics's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of TransMedics Group revenue and expense. TransMedics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, TransMedics' Cost Of Revenue is fairly stable compared to the past year. Reconciled Depreciation is likely to rise to about 6.1 M in 2024, whereas Net Loss is likely to drop (37.6 M) in 2024. View More FundamentalsTransMedics Stock Against Markets
Picking the right benchmark for TransMedics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in TransMedics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for TransMedics is critical whether you are bullish or bearish towards TransMedics Group at a given time. Please also check how TransMedics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in TransMedics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
TransMedics Corporate Management
Elected by the shareholders, the TransMedics' board of directors comprises two types of representatives: TransMedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TransMedics. The board's role is to monitor TransMedics' management team and ensure that shareholders' interests are well served. TransMedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TransMedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Miriam Provost | Vice Affairs | Profile | |
| Mark Anderson | Senior Development | Profile | |
| Susan Goodman | Vice Resources | Profile | |
| John Carey | VP Operations | Profile | |
| Nick Corcoran | Senior Operations | Profile | |
| Tamer MD | Chief Officer | Profile |
How to buy TransMedics Stock?
Before investing in TransMedics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in TransMedics. To buy TransMedics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of TransMedics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase TransMedics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located TransMedics Group stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased TransMedics Group stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as TransMedics Group, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy TransMedics Stock please use our How to Invest in TransMedics guide.
Already Invested in TransMedics Group?
The danger of trading TransMedics Group is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of TransMedics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than TransMedics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile TransMedics Group is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether TransMedics Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TransMedics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Transmedics Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Transmedics Group Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransMedics Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the TransMedics Group information on this page should be used as a complementary analysis to other TransMedics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for TransMedics Stock analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Is TransMedics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TransMedics. If investors know TransMedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TransMedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.77) | Revenue Per Share 7.431 | Quarterly Revenue Growth 1.587 | Return On Assets 0.0006 | Return On Equity (0.15) |
The market value of TransMedics Group is measured differently than its book value, which is the value of TransMedics that is recorded on the company's balance sheet. Investors also form their own opinion of TransMedics' value that differs from its market value or its book value, called intrinsic value, which is TransMedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TransMedics' market value can be influenced by many factors that don't directly affect TransMedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TransMedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if TransMedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TransMedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.